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Sarah Ratzel1 and Sara B. Cullinan2Genetically Controlled Methylation Clusters
Liu et al., 485
The high level of interest in how DNA methylation might
affect diverse human traits has prompted the develop-
ment of techniques aimed at studying this epigenetic
mark in a genome-wide manner. However, unlike their
cousins, genome-wide association studies, epigenome-
wide association studies (EWASs) lack a clear set of
guiding principles for their design, analysis, and interpre-
tation. Indeed, there is very little understanding of popu-
lation-level epigenetic properties. Consequently, the
conclusions drawn from the first generation of EWASs
have been the focus of considerable scrutiny. In this
study, Liu et al. found evidence that the clustering
of methylated CpGs is genetically driven. However,
they observed gaps in this clustering pattern, wherein
segments of methylation correlated with each other and
discrete SNPs surrounded regions of uncorrelated methyl-
ation. The authors term these correlated CpGs geneti-
cally-controlled methylation clusters, or GeMes. Just
how these clusters arise remains unknown, but the
authors suggest that nuclear organization might lead
to these noncontiguous yet correlated methylation
patterns. Although there is still much to be learned
about how methylation patterns affect human traits,
the identification of GeMes should help to inform the
design and interpretation of future experimentation in
this field.A Tool to Bring Function to GWASs
Pickrell, 559
Thousands of genome-wide association studies (GWASs)
have been performed, but from these, very few causal
variants (or molecular functions) have been identified.
The increasing wealth of functional genomic data pre-
sents an attractive source of information to aid in the
interpretation of GWAS data, but investigators face great
challenges in determining which data might be relevant
for a given biological trait. Through the examination of
18 traits and 450 genomic annotations, Pickrell presents
a method for integrating functional genomics data with
GWAS data, and it should improve the ability of investi-
gators to make sense of their findings. In short, the1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Amauthor developed a model that learns the shared proper-
ties of loci that are known to influence a given trait.
Armed with this knowledge, one could then devise
experiments to pinpoint exactly how a given variant
contributes to a particular biological outcome. In some-
thing of a surprise, Pickrell’s analysis revealed that
repressed chromatin, which accounts for well over half
of the genome, is depleted of loci that influence a diverse
range of human traits. In summary, this method will be
useful for a variety of purposes, including fine mapping,
obtaining information about relevant genomic annota-
tions and cell types, and boosting the ability of a given
GWAS to detect loci.Variant Prioritization Heats Up
Singleton et al., 599
In clinical exome sequencing, determining which variant
causes a disease can be difficult. Additionally, assigning
pathogenicity to a variant can be further complicated
because many times the variants in question are only
identified in a single individual or family. Variant prioriti-
zation can be a useful tool for narrowing the list of candi-
dates, and several methods of prioritization have been
created. In this study, Singleton et al. demonstrate the
utility of Phevor, a variant-prioritization tool that
combines the information found in many biomedical
ontologies—such as the Human Phenotype Ontology,
the Gene Ontology, and the Disease Ontology—with
variant-prioritization tools such as SIFT, ANNOVAR, and
VAAST. The output is a ranked list of candidates that are
sorted with the use of the information about gene func-
tion, disease, and phenotype. In an analysis of known
disease-causing mutations, Phevor outperformed four
different variant-prioritization tools in placing the gene
harboring the known variant at or near the top of the
candidate gene list. Moreover, this result was robust to
the removal of information about known gene-disease
associations and to atypical presentations of a given
phenotype. Using Phevor, the authors were able to use
single families to propose a previously undescribed gene-
disease association for a variant in NFKB2, describe a
STAT1 disease-causing variant with an atypical pheno-
typic presentation, and identify an ABCB11 allele associ-
ated with progressive familial intrahepatic cholestasisy of Human Genetics. All rights reserved.
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type 2. With both improvements in reporting and
sharing identified variants and tools like Phevor, assigning
pathogenicity for individuals and single families might be
heating up.FECHing a Treatment for Protoporphyria
Oustric et al., 611
In cases of seasonal disorders, a permanent gene-
therapy approach might not be the best option. Instead,
a treatment to provide relief during the time when
symptoms are present is all that might be required.
One such disease is erythropoietic protoporphyria
(EPP), which is characterized by acute photosensitivity
and, less commonly, hepatic complications. Many
cases of EPP are caused by a FECH rare variant that
is inherited in trans with a common polymorphism.
This polymorphism increases the use of a cryptic
splice site, leading to an mRNA isoform encoding a pre-
mature stop codon. FECH encodes a ferrochelatase
that inserts ferrous iron into free protoporhpyrin IX
(PPIX) and is the last enzymatic step in heme biosyn-
thesis. Consequently, individuals affected by EPP have
reduced FECH abundance and accumulate PPIX. In
this study, Oustric et al. targeted the cryptic splice site
by using an antisense oligonucleotide and demonstrated
improved production of wild-type FECH mRNA and
reduced accumulation of PPIX in erythroblasts from
EPP-affected individuals. However, future studies will
be needed for determining the optimal route for deliv-
ering these ASOs to the erythroid progenitors. Because
individuals with EPP are especially affected during
seasons during which increased sun exposure is com-
mon, periodic delivery of ASOs might be a useful thera-
peutic approach.482 The American Journal of Human Genetics 94, 481–482, April 3, 2SETtling 3p25 Microdeletion Syndrome
Grozeva et al., 618
It canbedifficult to assign thephenotypeof amicrodeletion
syndrome to a specific gene within the deleted interval.
Narrowing the critical region by identifying an overlap in
thedeletionofmultiple affected individuals andcomparing
the phenotype to those of individuals with mutations in a
single gene in the interval can point in a given direction,
but rarely are there enough individuals for causality tobe as-
signed. However, as large sequencing studies identify new
gene-disease associations, some of these questions might
be answered. For example, in this study, Grozeva et al.
screened almost 1,000 individuals at nearly 600 candidate
genes and identified seven variants in SETD5 in affected in-
dividuals with moderate to severe intellectual disability
(ID), brachycephaly, and shared facial features. In addition
to having these common features, some individuals
demonstrated behavioral problems, including obsessive
compulsive disorder. The frequency of thesemutations sug-
gests that disruption of this gene might cause approxi-
mately 0.7% of ID. SETD5 encodes a methytransferase, of
which several have previously been associated with ID.
Located in a genomic region thathas previously been impli-
cated in 3p25 microdeletion syndrome, SETD5 is one of
three critical-interval genes shared by multiple affected in-
dividuals. Like individuals who harbor SETD5 mutations,
individuals with 3p25 microdeletion syndrome typically
have ID andunique facial features. Coupledwith the shared
phenotypic similarity, this overlap between SETD5 and the
critical genomic region suggests that SETD5 loss of function
might cause many of the 3p25 microdeletion phenotypes.
As increasingly large sequencing studies are performed
and additional gene-disease associations are identified,
insights into additional microdeletion syndromes might
be gained through similar careful analyses.014
